According to previous studies, Vactosertib, an effective TGF-β signaling inhibitor, incredibly inhibits invasion and desmoplastic stroma when combined with other anti-cancer drugs in pancreatic cancer [26, 34]. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.